Dysfunctional macrophages along the gut-liver axis: a driver of infection in cirrhosis

Devrim Aslan1,2, Hannelie Korf1, Alexander Dumarey1

  • 1Laboratory of Liver Immunology, Leuven Center of Molecular Liver Sciences, Hepatology Research Unit, Department of Chronic Diseases and Metabolism (CHROMETA), KU Leuven, Leuven, Belgium.

Insights

Cirrhosis patients face high infection risks due to compromised gut-liver axis immunity. This review explores how intestinal and hepatic macrophages, crucial for barrier integrity, are dysregulated in cirrhosis, impacting disease progression.

Area of Science:

  • Immunology
  • Gastroenterology
  • Hepatology

Background:

  • Patients with cirrhosis exhibit heightened susceptibility to infections, often originating from the gut.
  • These infections can precipitate hepatic decompensation, organ failure, and mortality.
  • Macrophages are vital immune cells in the gut-liver axis, maintaining barrier integrity.

Purpose of the Study:

  • To review the heterogeneity of intestinal and hepatic macrophages.
  • To emphasize their distinct ontogeny and niche-specific functions.
  • To explore therapeutic strategies targeting macrophages in advanced liver disease.

Main Methods:

  • This is a review article, synthesizing current research on macrophage function in the gut-liver axis.
  • It discusses macrophage heterogeneity, ontogeny, and functional roles in health and cirrhosis.
  • Therapeutic approaches are explored based on existing literature.

Main Results:

  • In cirrhosis, macrophage specialization, organization, and antimicrobial functions are disrupted.
  • Understanding macrophage heterogeneity is key to comprehending gut-liver axis integrity.
  • Dysregulated macrophages contribute to compromised barrier functions in cirrhosis.

Conclusions:

  • Macrophages play critical roles in maintaining gut-liver barrier integrity.
  • Disruption of macrophage function in cirrhosis exacerbates infection susceptibility and disease progression.
  • Targeting macrophage dysregulation offers potential therapeutic avenues for advanced liver disease.

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammation01:38

Inflammation

Overview